0001580149 false 0001580149 2022-11-09 2022-11-09 iso4217:USD xbrli:shares iso4217:USD xbrli:shares
 

 

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549

     
     

FORM 8-K

     
     

CURRENT REPORT PURSUANT
TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported) November 9, 2022

 

BioVie Inc.
(Exact Name of Registrant as Specified in Its Charter)

 

Nevada 001-39015 46-2510769
(State or Other Jurisdiction
of Incorporation)		 (Commission File Number) (I.R.S. Employer
Identification No.)

 

680 W Nye Lane Suite 201

Carson City, NV

   89703
(Address of Principal Executive Offices)   (Zip Code)
     

(775) 888-3162
(Registrant’s Telephone Number, Including Area Code)
 

 

(Former Name or Former Address, if Changed Since Last Report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class Trading Symbol(s) Name of each exchange on which
registered
Class A Common Stock, par value $0.0001 per share BIVI The NASDAQ Stock Market, LLC

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

 

Item 5.07. Submission of Matters to a Vote of Security Holders.

 

On November 9, 2022, BioVie Inc., a Nevada corporation (the “Company”) held its 2022 Annual Meeting of stockholders (the “Annual Meeting”). The following matters were considered:

 

1. Election of Directors

 

Stockholders elected all of the Company’s nominees for director for one-year terms expiring at the next annual meeting of stockholders upon election and qualification of their successors. The voting results were as follows:

 

   For  Withhold  Broker Non-Vote
(1) TERREN S. PEIZER  23,780,558  184,068  1,760,515
(2) CUONG DO  23,916,874  37,752  1,760,515
(3) JIM LANG  23,889,937  74,689  1,760,515
(4) MICHAEL SHERMAN  23,917,129  37,497  1,760,515
(5) RICHARD J. BERMAN  23,832,311  132,315  1,760,515
(6) STEVE GORLIN  23,917,129  37,501  1,760,515
(7) ROBERT HARIRI, M.D. PHD  23,878,804  85,822  1,760,515
(8) SIGMUND ROGICH  23,923,084  41,542  1,760,515

 

2. Approval and Ratification of Auditors

 

Stockholders approved and ratified the appointment of EisnerAmper LLP to serve as the Company’s independent registered public accounting firm for the 2023 fiscal year. The voting results were as follows:

 

For  Against  Abstain  Broker Non-Vote
25,617,605  94,990  12,546  1,760,515

 

 

 -1-

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Dated: November 10, 2022

 

  BIOVIE INC.
     
  By: /s/ Joanne Wendy Kim
  Name: Joanne Wendy Kim
  Title: Chief Financial Officer

  

 -2-

 

BioVie (NASDAQ:BIVI)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more BioVie Charts.
BioVie (NASDAQ:BIVI)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more BioVie Charts.